SEC Form 4 · accession 0000905148-26-003146
BIODESIX INC · BDSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Patience
Director · Other
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001439725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2026 | M | 1,361 | — | A | 25,383 | D | |
| Common StockF2 | holding | — | — | — | 107,664 | I | By Patience Enterprises LP | |
| Common StockF3 | holding | — | — | — | 241,480 | I | By John Patience Living Trust dated 7/23/1993 | |
| Common Stock | holding | — | — | — | 2,649 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Jun 30, 2026 | M | 1,361 | D | — | — | Common Stock | 1,361 | 2,721 | D |
Explanation of responses
- F1Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
- F2The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
- F3The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
- F4These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.